Sunday, April 06, 2014 12:46:11 AM
“We are very excited to start working with Robson Capital and are moving ahead in a timely manner towards further development of our graphite interests,” states Peter Swistak, President and CEO of Cavan. “We are also carefully investigating and exploring potential opportunities in the medical marijuana sector, and look forward to working with Robson Capital in that regard as well.”
http://www.blog.robsoncapitalmarkets.com/2014/cavan-ventures-inc/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM